RUNX2 and prostate adenocarcinoma: RUNX1, RUNX2, and RUNX3 were all highly correlated with immune cell infiltration in the HNSC, KIRC, LGG, liver hepatocellular carcinoma (LIHC), and prostate adenocarcinoma (PRAD) (Figure S2A–S2C).